Search Results - nirmal+sharma

2 Results Sort By:
Biomarker for Chronic Lung Disease: N-Myc-Interactor (NMI)
Competitive Advantages NMI Diagnostic Biomarker: predicting chronic lung allograft dysfunction (CLAD) in lung transplant patients NMI as a novel therapeutic target, to increase its expression in chronic lung disease Summary Lung transplant remains the primary treatment option for patients with advanced lung disease or irreversible pulmonary failure....
Published: 5/20/2024   |   Inventor(s): Nirmal Sharma, Mudassir Banday, Andreas Seyfang
Keywords(s): Biomarker, Cancer Treatment Lung Cancer, Medical Diagnostics, Medical Therapeutics Gene Therapy, Therapeutics
Category(s): Technology Classifications > Medical > Respiratory, Technology Classifications > Medical
Lung Microbiome Isolation and Cultivation
­Competitive Advantages: Novel method to isolate, cultivate, and amplify the lung microbiome from a limited resource Beneficial for testing antibiotic sensitivity and drug resistance Enables lung microbiome transplantation for treatment of various chronic lung diseases Summary: Chronic lung diseases such as asthma, COPD, cystic fibrosis,...
Published: 9/3/2024   |   Inventor(s): Andreas Seyfang, Nirmal Sharma
Keywords(s): Cancer Treatment Lung Cancer, Health Tech, Microbiome
Category(s): Technology Classifications > Medical > Respiratory